Laryngopharyngeal Reflux (LPR): Clinical Trials

3 trials for Laryngopharyngeal Reflux (LPR), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 withdrawn. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Completed 1

Follow Laryngopharyngeal Reflux (LPR): new trials by email Literature Review of Laryngopharyngeal Reflux (LPR) trials Research Report on Laryngopharyngeal Reflux (LPR)

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Transoral Incisionless Fundoplication (TIF) for Laryngopharyngeal Reflux (LPR) Patients
Transoral Incisionless Fundoplication - Gastroesophageal Reflux Disease (GERD), Laryngopharyngeal Reflux (LPR)
WithdrawnBrigham and Women's Hospital2024-03-302024-08-05
Positive Predictive Value of the Dx-pH Probe for Predicting PPI Response in LPR
Laryngopharyngeal Reflux (LPR), Extraesophageal Reflux
CompletedNorthwestern University422012-08-012024-04-24
Quality of Life Validation in Laryngitis
Omeprazole, Quality of Life questionnaire - Laryngopharyngeal Reflux (LPR)
Phase 4CompletedAstraZeneca902001-05-012009-06-11

Narrower conditions

Laryngopharyngeal Reflux (3)  ·  Gastroesophageal Reflux (1)  ·  Laryngitis (1)

Broader conditions

Deglutition Disorders (3)  ·  Digestive System Diseases (3)  ·  Esophageal Diseases (3)  ·  Esophageal Motility Disorders (3)  ·  Gastrointestinal Diseases (3)  ·  Laryngeal Diseases (3)  ·  Respiratory Tract Diseases (3)  ·  Gastroesophageal Reflux (2)  ·  Infections (1)  ·  Otorhinolaryngologic Diseases (1)  ·  Respiratory Tract Infections (1)

Interventions

Omeprazole (1)

Sponsors

AstraZeneca (1)  ·  Brigham and Women's Hospital (1)  ·  Northwestern University (1)

Countries

United States (2)

Top investigators

Bruce Tan, MD (1)  ·  Christopher C. Thompson, MD (1)  ·  Paula Fernstrom (1)

Results publications

PMID 26689899, PMID 27091320